Phase II Trial Alternating FOLFOX-6 and FOLFIRI Regimens in Second-Line Therapy of Patients with Metastatic Colorectal Cancer (FIREFOX Study)

Author： Hebbar Mohamed   Tournigand Christophe   Lledo Gérard   Mabro May   André Thierry   Louvet Christophe   Aparicio Thomas   Flesch Michel   Varette Charles   de Gramont Aimery   Group (GERCOR) Oncology  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.24, Iss.2, 2006-05, pp. : 154-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

By                    

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 493-498

Spandidos Publications

Access to resources Recommend Favorite

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

By Maindrault-Goebel F.   Louvet C.   Andre T.   Carola E.   Lotz J.P.   Molitor J.L.   Garcia M.L.   Gilles-Amar V.   Izrael V.   Krulik M.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1338-1342

Elsevier

Access to resources Recommend Favorite

A Case of Ascending Colon Cancer with Local Recurrence Responding Completely to Alternating Modified-FOLFOX6 and FOLFIRI Regimens (Modified-FIREFOX Regimen)

By Matsutani Takeshi   Sasajima Koji   Suzuki Seiji   Matsushita Akira   Maruyama Hiroshi   Matsuda Akihisa   Miyamoto Masayuki   Yokoyama Tadashi   Sugiura Atsushi   Yanagi Ken   Nishi Yoshifumi   Arai Hiroki   Wakabayashi Hideyuki   Tajiri  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 505-507

Sunmedia

Access to resources Recommend Favorite

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By Rocha Lima Caio M.   Bayraktar Soley   Flores Aurea M.   MacIntyre Jessica   Montero Alberto   Baranda Joaquina C.   Wallmark John   Portera Chia   Raja Rajiv   Stern Howard   Royer-Joo Stephanie   Amler Lukas C.  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 727-731

Informa Healthcare

Access to resources Recommend Favorite

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

By Kochi Mitsugu   Akiyama Yuji   Aoki Tatsuya   Hagiwara Ken   Takahashi Takao   Hironaka Katsuji   Teranishi Futoshi   Osuka Fumihiko   Takeuchi Masahiro   Fujii Masashi   Nakajima Toshifusa  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1097-1102

Springer Publishing Company

Access to resources Recommend Favorite